BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38093367)

  • 1. USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity.
    Kwon J; Zhang J; Mok B; Allsup S; Kim C; Toretsky J; Han C
    Mol Cancer; 2023 Dec; 22(1):204. PubMed ID: 38093367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation.
    Quintanal-Villalonga A; Taniguchi H; Zhan YA; Hasan MM; Chavan SS; Meng F; Uddin F; Allaj V; Manoj P; Shah NS; Chan JM; Ciampricotti M; Chow A; Offin M; Ray-Kirton J; Egger JD; Bhanot UK; Linkov I; Asher M; Roehrl MH; Ventura K; Qiu J; de Stanchina E; Chang JC; Rekhtman N; Houck-Loomis B; Koche RP; Yu HA; Sen T; Rudin CM
    J Hematol Oncol; 2021 Oct; 14(1):170. PubMed ID: 34656143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma.
    Sato T; Yoo S; Kong R; Sinha A; Chandramani-Shivalingappa P; Patel A; Fridrikh M; Nagano O; Masuko T; Beasley MB; Powell CA; Zhu J; Watanabe H
    Cancer Res; 2019 Dec; 79(24):6084-6100. PubMed ID: 31551362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of USP13 drives non-small cell lung cancer progression mediated by AKT/MAPK signaling.
    Wu Y; Zhang Y; Liu C; Zhang Y; Wang D; Wang S; Wu Y; Liu F; Li Q; Liu X; Zaky MY; Yan D; Liu S
    Biomed Pharmacother; 2019 Jun; 114():108831. PubMed ID: 30986623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP13 promotes development and metastasis of high-grade serous ovarian carcinoma in a novel mouse model.
    Kwon J; Choi H; Ware AD; Morillo BC; Wang H; Bouker KB; Lu X; Waldman T; Han C
    Oncogene; 2022 Mar; 41(13):1974-1985. PubMed ID: 35173307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic KRAS effector USP13 promotes metastasis in non-small cell lung cancer through deubiquitinating β-catenin.
    Guo Y; Tian J; Guo Y; Wang C; Chen C; Cai S; Yu W; Sun B; Yan J; Li Z; Fan J; Qi Q; Zhang D; Jin W; Hua Z; Chen G
    Cell Rep; 2023 Dec; 42(12):113511. PubMed ID: 38043062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.
    Chen S; Giannakou A; Wyman S; Gruzas J; Golas J; Zhong W; Loreth C; Sridharan L; Yamin TT; Damelin M; Geles KG
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11671-E11680. PubMed ID: 30487219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
    Yu H; Pang Z; Li G; Gu T
    J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment.
    Mollaoglu G; Jones A; Wait SJ; Mukhopadhyay A; Jeong S; Arya R; Camolotto SA; Mosbruger TL; Stubben CJ; Conley CJ; Bhutkar A; Vahrenkamp JM; Berrett KC; Cessna MH; Lane TE; Witt BL; Salama ME; Gertz J; Jones KB; Snyder EL; Oliver TG
    Immunity; 2018 Oct; 49(4):764-779.e9. PubMed ID: 30332632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition.
    Pan Y; Han H; Hu H; Wang H; Song Y; Hao Y; Tong X; Patel AS; Misirlioglu S; Tang S; Huang HY; Geng K; Chen T; Karatza A; Sherman F; Labbe KE; Yang F; Chafitz A; Peng C; Guo C; Moreira AL; Velcheti V; Lau SCM; Sui P; Chen H; Diehl JA; Rustgi AK; Bass AJ; Poirier JT; Zhang X; Ji H; Zhang H; Wong KK
    Cancer Cell; 2023 Jan; 41(1):88-105.e8. PubMed ID: 36525973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma.
    Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J
    DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-restricted circular RNA circSOX2 suppressed the malignant progression in SOX2-amplified LUSC.
    Liang Y; Wang N; Zhang Y; Jiang W; Fang C; Feng Y; Ma H; Jiang F; Dong G
    Cell Death Dis; 2022 Oct; 13(10):873. PubMed ID: 36243874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a prognostic model toward lung squamous cell carcinoma based on m
    Wang Y; Liu Y; Wang R; Cao F; Guan Y; Chen Y; An B; Qin S; Yao S
    Physiol Genomics; 2023 Oct; 55(10):427-439. PubMed ID: 37575065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAK5 promotes the cell stemness ability by phosphorylating SOX2 in lung squamous cell carcinomas.
    Bao Z; Ji W; Yang Y; Chen Z; Li Z; Wang K; Lu T; Yu Y; Xia W; Lu S
    Exp Cell Res; 2020 Oct; 395(2):112187. PubMed ID: 32721391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple mutations of lung squamous cell carcinoma shared common mechanisms.
    Li Q; Hou J; Hu Z; Gu B; Shi Y
    Oncotarget; 2016 Nov; 7(48):79629-79636. PubMed ID: 27835590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin specific peptidase 47 promotes proliferation of lung squamous cell carcinoma.
    Yu L; Fu J; Shen C
    Genes Genomics; 2022 Jun; 44(6):721-731. PubMed ID: 35254655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal FGF19-GLI2 signaling induces epithelial-to-mesenchymal transition to promote lung squamous cell carcinoma metastasis.
    Zhang Y; Wu T; Wang Y; Chen Z; Chen J; Lu S; Xia W
    Cell Oncol (Dordr); 2023 Apr; 46(2):437-450. PubMed ID: 36598638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of ubiquitin-specific peptidase 13 inhibits cell growth of hepatocellular carcinoma by reducing c-Myc expression.
    Huang J; Gu ZL; Chen W; Xu YY; Chen M
    Kaohsiung J Med Sci; 2020 Aug; 36(8):615-621. PubMed ID: 32255563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental History Provides a Roadmap for the Emergence of Tumor Plasticity.
    Tata PR; Chow RD; Saladi SV; Tata A; Konkimalla A; Bara A; Montoro D; Hariri LP; Shih AR; Mino-Kenudson M; Mou H; Kimura S; Ellisen LW; Rajagopal J
    Dev Cell; 2018 Mar; 44(6):679-693.e5. PubMed ID: 29587142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.